Pyxis (PYXS) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan Pyxis Oncology Inc. (PYXS)

High demand for innovation in treating complex tumors creates immense potential for Pyxis Oncology, Inc. (PYXS). The company's developments are independent of economic cycles or seasonality, which guarantees stability. The company's cash balance on the GURU.Markets dynamic chart currently stands at 0.06, however, the lack of stable revenue makes the financial position dependent on existing capital.

PYXS - Cadangan dhuwit perusahaan pyxisoncology.com ing rentang 04.07.2022 - 21.11.2026

Rincian analitis perusahaan Pyxis Oncology, Inc.

Pambiji fundamental perusahaan:Pyxis Oncology PYXS
Produk merek Pyxis Oncology, Inc.

The investment attractiveness of Pyxis Oncology, Inc. (PYXS) depends on its ability to fund development without in-house production. This indicator captures the daily dynamics of liquid assets, reflecting the real-time burn rate between quarterly reports. By analyzing changes in cash levels, investors assess the company's financial runway when delegating antibody synthesis to external CDMO contractors. A stable cash balance confirms operational resilience and minimizes the risk of underfunding key laboratory research.

Pesaing Pyxis Oncology, Inc. (PYXS)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Dana dhuwit perusahaan|Immatics N.V. - Sisa dhuwit perusahaan|XNCR (xencor.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Compass Therapeutics Inc|Dana dhuwit perusahaan Replimune (REPL)|LYEL: Total volume dana dhuwit perusahaan|Innate Pharma SA - Dhuwit awis perusahaan|Compugen Limited (CGEN) - Cadangan dhuwit perusahaan|IO Biotech Inc - Volume dana dhuwit perusahaan|Aset likuid perusahaan Sutro Bio STRO|INKT: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Werewolf (HOWL)|Dana dhuwit perusahaan immixbio.com|Dhuwit awis lan setara dhuwit awis perusahaan ALXO (ALX Oncology)|Volume dana dhuwit perusahaan CUE|PDSB (PDS Biotechnology Corporation) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SONN (Sonnet BioTherapeutics Holdings)|Sisa dhuwit perusahaan MAIA|Liminatus - Volume dana dhuwit perusahaan|lavatherapeutics.com - Gunggung dana dhuwit perusahaan|NextCure (NXTC) - Dana dhuwit perusahaan|Leap Therapeutics Inc - Sisa dhuwit perusahaan|Dhuwit awis perusahaan INTS|Dana dhuwit perusahaan SNSE|Volume dana dhuwit perusahaan TOVX|GRTS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan kinetabio.com KA|Sisa dhuwit perusahaan NEXI|turnstonebio.com - Volume dana dhuwit perusahaan|VCNX (Vaccinex, Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan